KEAP1 and TP53 (Co)mutation in Lung Adenocarcinoma: Another Bullet for Immunotherapy? Pelosi G. J Thorac Oncol 2021;16:1979-1983.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pelosi G. KEAP1 and TP53 (Co)mutation in Lung Adenocarcinoma: Another Bullet for Immunotherapy? J Thorac Oncol 2021;16:1979-1983.
PMID: 34809800